Arrowhead Research (ARWR -7%) slides today after pricing its 1.65 million unit public offering...

|About: Arrowhead Pharmaceuticals (ARWR)|By:, SA News Editor

Arrowhead Research (ARWR -7%) slides today after pricing its 1.65 million unit public offering at $2.12 per unit. Each unit consists of one share of common stock and one warrant to purchase 0.50 of a share of common. The company intends to use the net proceeds for general corporate purposes, including R&D and clinical trial expenditures,